4月8日,据外媒报道,细胞分析公司Celcuity宣布与辉瑞公司达成全球许可协议,辉瑞将gedatolisib(一种1b期pan-PI3K / mTOR抑制剂)专有权授予给Celcuity。Gedatolisib正在临床开发中,用于治疗ER + / HER2-阴性的晚期或转移性乳腺癌患者。
根据许可协议条款,辉瑞向Celcuity提...查看全文
美股 美股开盘 | 三大指数涨跌不一,搜狐(SOHU.US)涨超13% 2021年4月9日 20:31:45 智通财经APP获悉,4月9日(周五)美股开盘,三大指数涨跌不一。截至发稿,道指涨0.18%,标普500指数跌0.03%,纳指跌0.41%。 个股消息 细胞分析公司Celcuit... 网页链接
格隆汇4月9日丨Celcuity(CELC.US)盘前大涨38.78%报19.86美元。公司周四表示,已与辉瑞公司签署了一项全球许可协议,获得了开发和商业化辉瑞Gedatolisib的全球许可。Gedatolisib正处于临床开发阶段,用于治疗某些类型的乳腺癌患者。Celcuity表示:“来自103... 网页链接
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000914190-19-000457 Size: 5 KB 网页链接
$Celcuity(CELC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-07 AccNo: 0001654954-19-012489 Size: 2 MB 网页链接
$Celcuity(CELC)$ 8-K - Current report Filed: 2019-11-07 AccNo: 0001654954-19-012490 Size: 229 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celcuity(CELC)$ D/A [Amend] - Notice of Exempt Offering of Securities Filed: 2019-10-31 AccNo: 0001437749-19-020955 Size: 13 KB 网页链接
$Celcuity(CELC)$ D/A [Amend] - Notice of Exempt Offering of Securities Filed: 2019-10-31 AccNo: 0001437749-19-020960 Size: 13 KB 网页链接
$Celcuity(CELC)$ 8-K - Current report Filed: 2019-08-08 AccNo: 0001144204-19-038611 Size: 147 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celcuity(CELC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-08 AccNo: 0001144204-19-038618 Size: 3 MB 网页链接
$Celcuity(CELC)$ 美东时间 2019-08-08 盘后 披露财报,预期EPS -0.2 网页链接
$Celcuity(CELC)$ 8-K - Current report Filed: 2019-06-17 AccNo: 0001144204-19-031179 Size: 16 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Celcuity(CELC)$ 8-K - Current report Filed: 2019-05-20 AccNo: 0001144204-19-027333 Size: 44 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of ...